Pular para o conteúdo principal
Ranking Invest

IOVA - Iovance Biotherapeutics, Inc.

Segmento: HealthcareIovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or persistent cervical cancer; and C-145-03, of its product candidate LN-145, for recurrent and/or metastatic head and neck squamous cell carcinoma. Iovance Biotherapeutics, Inc. has collaborations and licensing agreements with H. Lee Moffitt Cancer Center; M.D. Anderson Cancer Center; Ohio State University; Centre hospitalier de l'Université de Montreal; Cellectis S.A.; and Novartis Pharma AG. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California.

Análise Ranking Invest

Valor de Mercado
$ 6.60 Bi
IVR
-0.10Índice proprietário de comparação relativa: -0,10.
IVR2
-0.21Leitura proprietária complementar: -21%.
MLL
-0.21Leitura proprietária complementar: -21%.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia proprietária baseada em dados financeiros públicos; fórmulas e valores intermediários são confidenciais.

Dados da Empresa

Patrimônio Líquido

$ 736.04 Mi

Dívida Líquida

-$ 110.77 Mi

L4T

-$ 289.52 Mi

MM4T

-94.11%

Indicadores Básicos

ROE

-39.33%

Índices de Previsibilidade

Receita Líquida

F0.53

Lucro

A0.13

Margem

E1.19

Índices de Tendência

Receita Líquida

A11.01

Lucro

B7.38

Margem

B4.63

Índices de Endividamento

DIV/PAT

-0.15

DIV/L4T

0.38

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.